Antibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii

BACKGROUND: Successful treatment of Acinetobacter (A.) baumannii-associated infection is complicated by the emergence of multidrug resistance (MDR), particularly in clinical settings. This urges searching for new alternatives to encounter such health problem. AIM: This study aimed to evaluate certai...

Descripción completa

Detalles Bibliográficos
Autores principales: Banoub, Nancy G, Saleh, Sarra E, Helal, Hala S, Aboshanab, Khaled M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384262/
https://www.ncbi.nlm.nih.gov/pubmed/34447258
http://dx.doi.org/10.2147/IDR.S328788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384262/
https://www.ncbi.nlm.nih.gov/pubmed/34447258
http://dx.doi.org/10.2147/IDR.S328788

Ejemplares similares